cyanopindolol has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cremaschi, GA; Edgar, VA; Genaro, AM; Sterin-Borda, L | 1 |
Cremaschi, G; Fernández, MM; Fossati, CA; Goin, JC; Gorelik, G; Malchiodi, EL; Zwirner, NW | 1 |
2 other study(ies) available for cyanopindolol and cyclic gmp
Article | Year |
---|---|
Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine.
Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents, Second-Generation; Autonomic Nervous System; B-Lymphocytes; CD4-CD8 Ratio; Cell Division; Chronic Disease; Cyclic AMP; Cyclic GMP; Disease Models, Animal; Female; Fluoxetine; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mitogens; Muscarinic Antagonists; Pindolol; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Adrenergic, beta; Receptors, Muscarinic; Stress, Psychological; T-Lymphocytes; Tritium | 2002 |
Modulatory effects on myocardial physiology induced by an anti-Trypanosoma cruzi monoclonal antibody involve recognition of major antigenic epitopes from beta1-adrenergic and M2-muscarinic cholinergic receptors without requiring receptor cross-linking.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Protozoan; Binding, Competitive; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Epitopes; Immunoglobulin Fab Fragments; In Vitro Techniques; Iodine Isotopes; Mice; Mice, Inbred BALB C; Muscarinic Antagonists; Myocardial Contraction; Pindolol; Quinuclidinyl Benzilate; Radioimmunoassay; Radioligand Assay; Receptor, Muscarinic M2; Receptors, Adrenergic, beta-1; Titrimetry; Trypanosoma cruzi | 2004 |